Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Praxis Precision Medicine Analyst Ratings and Price Targets | NASDAQ:PRAX | Benzinga
Praxis Precision Medicines Inc has a consensus price target of $112.91 based on the ratings of 12 analysts. The high is $270 issued by Piper Sandler on July 1, 2024. The low is $4 issued by B of A Securities on June 7, 2022. The 3 most-recent analyst ratings were released by Truist Securities, Baird, and Needham on March 3, 2025, respectively. With an average price target of $81 between Truist Securities, Baird, and Needham, there's an implied 109.68% upside for Praxis Precision Medicines Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Baird
Needham
HC Wainwright & Co.
Deutsche Bank
1calculated from analyst ratings
Analyst Ratings for Praxis Precision Medicine
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/03/2025 | Buy Now | 120.04% | Truist Securities | Joon Lee78% | $175 → $85 | Maintains | Buy | Get Alert |
| 03/03/2025 | Buy Now | 88.97% | Baird | Joel Beatty68% | $117 → $73 | Maintains | Outperform | Get Alert |
| 03/03/2025 | Buy Now | 120.04% | Needham | Ami Fadia62% | $150 → $85 | Maintains | Buy | Get Alert |
| 03/03/2025 | Buy Now | 171.81% | HC Wainwright & Co. | Douglas Tsao53% | $120 → $105 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 187.34% | Deutsche Bank | David Hoang42% | → $111 | Initiates | → Buy | Get Alert |
| 02/10/2025 | Buy Now | 288.3% | Needham | Ami Fadia62% | $150 → $150 | Reiterates | Buy → Buy | Get Alert |
| 01/21/2025 | Buy Now | 353.02% | Truist Securities | Joon Lee78% | $150 → $175 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 210.64% | HC Wainwright & Co. | Douglas Tsao53% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | Buy Now | 210.64% | HC Wainwright & Co. | Douglas Tsao53% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | Buy Now | 290.89% | Needham | Ami Fadia62% | $151 → $151 | Reiterates | Buy → Buy | Get Alert |
| 10/31/2024 | Buy Now | 321.95% | Oppenheimer | Francois Brisebois43% | $143 → $163 | Maintains | Outperform | Get Alert |
| 09/10/2024 | Buy Now | 210.64% | HC Wainwright & Co. | Douglas Tsao53% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | 290.89% | Needham | Ami Fadia62% | $151 → $151 | Reiterates | Buy → Buy | Get Alert |
| 09/04/2024 | Buy Now | 270.18% | Oppenheimer | Francois Brisebois43% | $134 → $143 | Reiterates | Outperform → Outperform | Get Alert |
| 09/04/2024 | Buy Now | 290.89% | Needham | Ami Fadia62% | $145 → $151 | Maintains | Buy | Get Alert |
| 09/03/2024 | Buy Now | 210.64% | HC Wainwright & Co. | Douglas Tsao53% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | 275.36% | Needham | Ami Fadia62% | $145 → $145 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | 210.64% | HC Wainwright & Co. | Douglas Tsao53% | $105 → $120 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 24.26% | Wedbush | Laura Chico48% | $40 → $48 | Maintains | Neutral | Get Alert |
| 08/14/2024 | Buy Now | 246.88% | Oppenheimer | Francois Brisebois43% | $134 → $134 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2024 | Buy Now | 340.07% | Guggenheim | Yatin Suneja48% | $155 → $170 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 275.36% | Needham | Ami Fadia62% | $145 → $145 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 275.36% | Needham | Ami Fadia62% | $145 → $145 | Reiterates | Buy → Buy | Get Alert |
| 08/05/2024 | Buy Now | 246.88% | Oppenheimer | Francois Brisebois43% | → $134 | Initiates | → Outperform | Get Alert |
| 07/01/2024 | Buy Now | 598.94% | Piper Sandler | Yasmeen Rahimi61% | $270 → $270 | Maintains | Overweight | Get Alert |
| 06/24/2024 | Buy Now | 275.36% | Needham | Ami Fadia62% | → $145 | Initiates | → Buy | Get Alert |
| 06/18/2024 | Buy Now | 301.24% | Guggenheim | Yatin Suneja48% | → $155 | Initiates | → Buy | Get Alert |
| 05/16/2024 | Buy Now | 288.3% | Truist Securities | Joon Lee78% | $150 → $150 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | 171.81% | HC Wainwright & Co. | Douglas Tsao53% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | 202.87% | Baird | Joel Beatty68% | → $117 | Initiates | → Outperform | Get Alert |
| 04/26/2024 | Buy Now | 171.81% | HC Wainwright & Co. | Douglas Tsao53% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 03/26/2024 | Buy Now | 171.81% | HC Wainwright & Co. | Douglas Tsao53% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 03/26/2024 | Buy Now | 231.35% | Jefferies | Kambiz Yazdi60% | $75 → $128 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | 171.81% | HC Wainwright & Co. | Douglas Tsao53% | $105 → $105 | Reiterates | Buy → Buy | Get Alert |
| 01/12/2024 | Buy Now | -24.93% | Wedbush | Laura Chico48% | $16 → $29 | Maintains | Neutral | Get Alert |
| 12/05/2023 | Buy Now | 171.81% | HC Wainwright & Co. | Douglas Tsao53% | → $105 | Reiterates | Buy → Buy | Get Alert |
| 12/04/2023 | Buy Now | 288.3% | Truist Securities | Joon Lee78% | → $150 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2023 | Buy Now | -81.88% | HC Wainwright & Co. | Douglas Tsao53% | → $105 | Reiterates | Buy → Buy | Get Alert |
| 10/03/2023 | Buy Now | -94.82% | Wedbush | Laura Chico48% | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 09/19/2023 | Buy Now | -74.11% | Truist Securities | Joon Lee78% | → $150 | Initiates | → Buy | Get Alert |
| 08/10/2023 | Buy Now | -81.88% | HC Wainwright & Co. | Douglas Tsao53% | $225 → $105 | Maintains | Buy | Get Alert |
| 08/09/2023 | Buy Now | -61.17% | HC Wainwright & Co. | Douglas Tsao53% | → $225 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | -94.82% | Wedbush | Laura Chico48% | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 06/12/2023 | Buy Now | -61.17% | HC Wainwright & Co. | Douglas Tsao53% | → $225 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | -89.65% | Jefferies | Kambiz Yazdi60% | → $60 | Initiates | → Buy | Get Alert |
| 05/12/2023 | Buy Now | -94.82% | Wedbush | Laura Chico48% | → $30 | Reiterates | → Neutral | Get Alert |
| 05/12/2023 | Buy Now | -61.17% | HC Wainwright & Co. | Douglas Tsao53% | → $225 | Reiterates | Buy → Buy | Get Alert |
| 04/14/2023 | Buy Now | -58.58% | HC Wainwright & Co. | Douglas Tsao53% | → $240 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | Buy Now | — | William Blair | Myles Minter44% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/06/2023 | Buy Now | -58.58% | HC Wainwright & Co. | Douglas Tsao53% | → $240 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | Buy Now | -58.58% | HC Wainwright & Co. | Douglas Tsao53% | → $240 | Reiterates | → Buy | Get Alert |
| 02/03/2023 | Buy Now | -58.58% | HC Wainwright & Co. | Douglas Tsao53% | → $240 | Reiterates | → Buy | Get Alert |
| 06/08/2022 | Buy Now | -53.4% | Piper Sandler | Yasmeen Rahimi61% | $975 → $270 | Maintains | Overweight | Get Alert |
| 06/07/2022 | Buy Now | -74.11% | HC Wainwright & Co. | Douglas Tsao53% | $720 → $150 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | -89.65% | B of A Securities | Tazeen Ahmad55% | $390 → $60 | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Praxis Precision Medicine (PRAX) stock?
The latest price target for Praxis Precision Medicine (NASDAQ:PRAX) was reported by Truist Securities on March 3, 2025. The analyst firm set a price target for $85.00 expecting PRAX to rise to within 12 months (a possible 120.04% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Praxis Precision Medicine (PRAX)?
The latest analyst rating for Praxis Precision Medicine (NASDAQ:PRAX) was provided by Truist Securities, and Praxis Precision Medicine maintained their buy rating.
When was the last upgrade for Praxis Precision Medicine (PRAX)?
There is no last upgrade for Praxis Precision Medicine
When was the last downgrade for Praxis Precision Medicine (PRAX)?
The last downgrade for Praxis Precision Medicines Inc happened on March 6, 2023 when William Blair changed their price target from N/A to N/A for Praxis Precision Medicines Inc.
When is the next analyst rating going to be posted or updated for Praxis Precision Medicine (PRAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Praxis Precision Medicine, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Praxis Precision Medicine was filed on March 3, 2025 so you should expect the next rating to be made available sometime around March 3, 2026.
Is the Analyst Rating Praxis Precision Medicine (PRAX) correct?
While ratings are subjective and will change, the latest Praxis Precision Medicine (PRAX) rating was a maintained with a price target of $175.00 to $85.00. The current price Praxis Precision Medicine (PRAX) is trading at is $38.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.